Search

everythinglearnresearchcommunity

for

Search:↓

The immune processes causing VKH and vitiligo are similar in dogs and humans.

People with Lichen Planopilaris are more likely to have autoimmune diseases, especially Systemic Lupus Erythematosus, and less likely to have diabetes and some other common conditions.

Using systemic drugs as creams for skin conditions shows promise, but more research is needed to confirm their effectiveness and safety.

Vogt-Koyanagi-Harada disease can develop during interferon therapy for chronic hepatitis C.

Chinese patients with systemic lupus erythematosus commonly experience oral ulcers, arthritis, alopecia, skin rash, and nephritis.

Seven patients were misdiagnosed with discoid lupus instead of lichen planopilaris due to similar symptoms, showing the need for careful diagnosis in scarring hair loss conditions.

A rabbit with sebaceous adenitis was effectively treated with ciclosporin and medium-chain triglycerides.

Targeting immune tolerance issues in Alopecia Areata could restore hair growth and maintain remission.

Skin changes can indicate hormonal imbalances and help diagnose endocrine disorders.

People with vitiligo may have a higher rate of Helicobacter pylori infection, but the infection's severity doesn't affect how severe the vitiligo is.

Alopecia can be reversed with timely steroid treatment in VKH and SO diseases.

Malondialdehyde-modified DNA may trigger an immune response in alopecia areata patients.

Most treatments for Frontal Fibrosing Alopecia are ineffective, but early anti-inflammatory therapy may help and the condition may stabilize over time.

Higher inflammation markers are linked to more severe alopecia areata.

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

Skin and hair changes in horses can indicate serious diseases, and recognizing these signs is important for treatment and management.

Most children with MIS-C showed significant improvement by 6 months.

The symposium concluded that a specific lipid might cause hair loss, inflammation is a key factor, and stem cells in bald scalps aren't working right, suggesting new treatment targets.

Oxidative stress may contribute to hair loss in alopecia areata and antioxidants could potentially help as a treatment.

Genetic testing is crucial before giving azathioprine to avoid severe side effects.

Hair loss in Cronkhite-Canada syndrome may be caused by autoimmune factors, not just stress or malabsorption.

CBD can either promote or inhibit hair growth depending on the concentration used.

Telogen Effluvium is a hair loss condition where treatment involves identifying and managing its triggers.

Enhancing regulatory T cells may help treat autoimmune diseases like alopecia areata.

COVID-19 can worsen autoimmune skin diseases and increase their occurrence.

Higher IL-15 levels are linked to more severe hair loss in alopecia areata.

Hair loss in Cronkhite-Canada syndrome may be due to an autoimmune response.

Early treatment of acne is crucial to prevent scarring and psychological effects.

Autoimmune markers may help diagnose and manage PCOS.

Phosphorus may help treat alopecia areata.